Teva launches generic version of EpiPen for young children

Teva Pharmaceutical Industries Ltd on Tuesday made its generic version of Mylans EpiPen for young children available in most retail pharmacies at $300 for a 2-pack. U.S-listed shares of the Israel-based company rose 4.9% to $7 in afternoon trading. Teva, the worlds largest generic drugmaker, is already selling the product for adults, after getting U.S. approval for its copy of EpiPen last August, following several years of delay.

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.001193 seconds